Literature DB >> 19279426

Anal submucosal carbon bead injection for treatment of idiopathic fecal incontinence: a preliminary report.

Felix Aigner1, Friedrich Conrad, Raimund Margreiter, Michael Oberwalder.   

Abstract

PURPOSE: Submucosal injection of bulking agents is a treatment option for idiopathic fecal incontinence. This study sought to assess whether the injection of carbon beads can significantly improve anal continence.
METHODS: Consecutive patients presenting with fecal incontinence were evaluated with standardized incontinence grading and quality-of-life grading scores, by anoproctoscopy, endoanal ultrasound, and anomanometry before, 3, 6, 12, and 24 months after injection. Injection therapy was performed in patients with anatomically intact anal sphincters. Patients kept a two-week incontinence diary. Data were obtained from a two-year follow-up period.
RESULTS: Eleven women with a mean age of 66 (range, 56 to 74) years met the inclusion criteria. Mean incontinence score was 12.27 +/- 0.97 at baseline, 6.82+/-1.64 at three-month, 6.73 +/- 1.47 at six-month, 5.91 +/- 0.95 at one-year, and 4.91 +/- 0.87 at two-year follow-up (P = 0.003). Quality-of-life items like coping and embarrassment improved significantly from baseline 2.3 to 3 at three months and 2.8 at six months (P < 0.05). Anomanometry showed a trend toward increase in measured pressures. No major complications occurred.
CONCLUSIONS: The injection of carbon beads via an intersphincteric approach is a promising new treatment option for old patients with idiopathic fecal incontinence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279426     DOI: 10.1007/DCR.0b013e318197d755

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

Review 1.  Current status: new technologies for the treatment of patients with fecal incontinence.

Authors:  Andreas M Kaiser; Guy R Orangio; Massarat Zutshi; Suraj Alva; Tracy L Hull; Peter W Marcello; David A Margolin; Janice F Rafferty; W Donald Buie; Steven D Wexner
Journal:  Surg Endosc       Date:  2014-03-08       Impact factor: 4.584

Review 2.  Midterm outcomes of injectable bulking agents for fecal incontinence: a systematic review and meta-analysis.

Authors:  K D Hong; J S Kim; W B Ji; J W Um
Journal:  Tech Coloproctol       Date:  2017-03-01       Impact factor: 3.781

3.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

4.  The use of Permacol® injections for the treatment of faecal incontinence.

Authors:  Zeiad I Hussain; Michael Lim; Haider Mussa; Kazim Abbas; Stevan Stojkovic
Journal:  Updates Surg       Date:  2012-09-05

5.  Treatment of fecal incontinence - review of observational studies (OS) and randomized controlled trials (RCT) related to injection of bulking agent into peri-anal tissue.

Authors:  Felix W Leung
Journal:  J Interv Gastroenterol       Date:  2011-10-01

6.  Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence.

Authors:  A Mellgren; K E Matzel; J Pollack; T Hull; M Bernstein; W Graf
Journal:  Neurogastroenterol Motil       Date:  2014-05-19       Impact factor: 3.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.